Cardinal Health, Inc. (CAH) all U.S. Lobbying: all historical lobbying contracts, government bills & agencies, and critical issues lobbied on.

$99.95

Discover Cardinal Health, Inc.’s lobbying activities with our comprehensive dataset, offering insights on spending, bills, and issues from 1999-present. Analyze data by company, lobbyist, issue, and more through our intelligently crafted data design. Dataset updated weekly.

Description

Using our intelligently designed and intuitive dataset, you can quickly understand how Cardinal Health, Inc. (CAH) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.

Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.

For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.

Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.

Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:

1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.

2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.

3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).

4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.

5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).

6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).

7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).

Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].

Frequently Asked Questions

What is Cardinal Health, Inc. (CAH) lobbying for?

Summary of Cardinal Health, Inc.’s lobbying data:

– Lobbying firms hired: Twenty-First Century Group, Cardinal Health, Tarplin, Inc., Llc, Downs & Young, Crowell & Moring Llp
– General issues they lobbied on: Manufacturing, Civil Rights/Civil Liberties, Disaster Planning/Emergencies, Pharmacy, Health Issues, Railroads, Energy/Nuclear, Tariff (miscellaneous tariff bills), Budget/Appropriations
– Specific issues they lobbied on:
– Implementation of the American Rescue Plan of 2021 (H.R. 5376)
– Education on supply chain issues
– IT interoperability for the Strategic National Stockpile
– Consolidated Appropriations Act and pandemic response
– Ports and transportation issues including the Ocean Shipping Reform Act of 2022 (S. 3850/H.R. 4996)
– Exclusion of healthcare-related products in section 301 tariffs
– Reimbursement for Vaccine Network Administrators
– Equitable Community Access to Pharmacist Services Act and Drug Pricing
– VALID Act (H.R. 4128/ S. 2209)
– Appropriations report language requests in support of a Medical Distribution Supply Chain Task Force
– H.R. 5- Equality Act and S.393 – Equality Act
– Inflation Reduction Act covid-19 vaccine distribution
– Buy America, biosimilars, and product shortages; S.3799 – PREVENT Pandemics Act
– H.R. 1319, Bipartisan Innovation Act and CHIPS for America Act
– Workforce shortages, domestic manufacturing, and product shortages, pandemic preparedness
– Issues related to drug pricing, federal pharmacy program
– Saving Access to Laboratory Services Act (SALSA) (HR 8188/S 4449); Improving Seniors Timely Access to Care Act of 2021 (HR 3173/S 3018); Issues related to Medicare provider cuts; Issues related to glucose monitors, and DIR fees
– H.R. 7213- Equitable Community Access to Pharmacist Services Act; H.R. 7053- The Hospital Inpatient Services Modernization Act
– 2023 covid-19 vaccine distribution
– Issues related to COVID-19, raw material shortages, provider status, and supply chain
– Equality Act (H.R. 5/S. 393); Respect for Marriage Act (H.R.8404), and DIR fees
– H.R. 72
– Government agencies they lobbied: White House Office, Centers For Disease Control & Prevention (CDC), House of Representatives, Department of Health & Human Services (HHS), Senate, Department of Defense (DOD), U.S. Trade Representative (USTR), Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), Department of Commerce (DOC)

One could infer that Cardinal Health, Inc. is lobbying on a wide range of issues related to healthcare and manufacturing because they are a healthcare services and products company. As such, they likely want to have a say in legislation and policies that could impact their industry and their operations. The specific issues they lobbied on indicate concerns around COVID-19 response, supply chain issues, and reimbursement for healthcare services and products. They also lobbied on issues related to pharmaceuticals and medical devices, such as drug pricing, federal pharmacy programs, and the VALID Act. Additionally, their lobbying targets suggest they want to influence policy at many levels of government, including the White House, Congress, and government agencies like the Department of Health and Human Services and the Centers for Medicare and Medicaid Services.

Subscribe To Our Newsletter

gain actionable insights from our alternative data

More to explore